Rescue by cytokines of apoptotic cell death induced by IL-2 deprivation of human antigen-specific T cell clones

Clinical and Experimental Immunology

Volumn 109, Issue 1, 1997, Pages 185-193

  Kaneko, S ^a,b   Suzuki, N ^a   Koizumi, H ^a   Yamamoto, S ^b   Sakane, T ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Human antigen specific; IFN STAT; T cell clone apoptosis

Indexed keywords

ALPHA INTERFERON; GROWTH FACTOR; INTERLEUKIN 2;

APOPTOSIS; ARTICLE; CELL CLONING; CELL DEATH; DIAGNOSIS; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0030738380     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4191324.x     Document Type: Article

References (46)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
2. Martin SJ, Green DR, Cotter TG. Dicing with death: dissecting the components of the apoptosis machinery. Trends Biochem Sci 1994; 19:26-30.
3. Kroemer G, Petit P, Zamzami N, Vayssiére J-L, Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9:1277-87.
4. Carson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993; 341:1251-4.
5. Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991; 7:663-98.
6. Gagliardini V, Fernandez P-A, Lee RKK, Drexler HCA, Rotello RJ, Fishman MC, Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science 1994; 263:826-8.
7. Nicholson DW, Ali A, Thornberry NA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376:37-43.
8. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomci LD, Barr PJ. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995; 374:736-9.
9. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ, Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80:285-91.
10. Lassus P, Ferlin M, Piette J, Hibner U. Anti-apoptotic activity of low levels of wild-type p53. EMBO J 1996; 15:4566-73.
11. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995; 13:513-43.
12. Lenardo MJ. Interleukin-2 programs mouse α/β T lymphocytes for apoptosis. Nature 1991; 353:858-61.
13. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991; 9:243-69.
14. Suzuki N, Bianchi E, Bass H et al. Natural killer lines and clones with apparent antigen-specificity. J Exp Med 1990; 172:457-62.
15. +) established by repetitive stimulation with a serotype (KTH-1) of a Gram-positive bacterium. Streptococcus sanguis: Eur J Immunol 1994; 24:1536-43.
16. Duke RC, Cohen JJ. Morphological and biochemical assays of apoptosis. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current protocols in immunology. New York: Greene Publishing/Wiley-Interscience, 1992: Unit 3.17.1.
17. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1992; 1133:275-85.
18. Koizumi H, Wakisaka M, Nakada K, Takakuwa T, Fujioka T, Yamate N, Uchikoshi T. Demonstration of apoptosis in neuroblastoma and its relation to tumour regression. Virchows Arch 1995; 427:167-73.
19. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991; 139:271-9.
20. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
21. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11:1475-89.
22. Ohlsson H, Edlund T. Sequence-specific interactions of nuclear factors with the insulin gene enhancer. Cell 1986; 45:35-44.
23. Sambrook J, Fritsch EF, Maniatis T. Transfection mediated by DEAE-Dextran. In: Sambrook J, Fritsch EF, Maniatis T, eds. Molecular cloning, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1989:16.41.
24. Ihle JN. Cytokine receptor signaling. Nature 1995; 377:591-4.
25. Leung S, Qureshi SA, Kerr IM, Darnell JE Jr, Stark GR. Role of STAT2 in the alpha interferon signaling pathway. Mol Cell Biol 1995; 15:1312-7.
26. Fu X-Y, Schindler C, Improta T, Aebersold R, Darnell JE Jr. The proteins of ISGF-3, the interferon α-induced transcriptional activator. define a gene family involved in signal transduction. Proc Natl Acad Sci USA 1992; 89:7840-3.
27. Hou J, Schindler U, Henzel WJ, Wong SC, McKnight SL. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 1995; 2:321-9.
28. Nielsen M, Svejgaard A, Skov S, Ødum N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol 1994; 24:3082-6.
29. Fu X-Y. A transcription factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s). Cell 1992; 70:323-35.
30. Kroemer G. The pharmacology of T cell apoptosis. Adv Immunol 1995; 58:211-96.
31. Sprent J. T lymphocytes and the thymus. In: Paul WE, ed. Fundamental immunology, 3rd edn. New York: Raven Press, 1993:75-109.
32. Akhar AN, Salmon M, Savill J, Janossy G. A possible role for bcl-2 in regulating T-cell memory - a 'balancing act' between cell death and survival. Immunol Today 1993; 14:526-32.
33. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272:1947-50.
34. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV. Alpha-interferon (α-IFN) protects B-chronic lymphocytic leukaemia cells from apoptolic cell death in vitro. Br J Haematol 1994; 86:169-73.
35. Scott S, Pandolfi F, Kurnick JT. Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells. J Exp Med 1990; 172:1873-6.
36. Dao T, Ariyasu T, Holçn V, Minowada J. Natural human interferon-α augments apoptosis in activated T cell line. Cell Immunol 1994; 155:304-11.
37. Nakayama K-I, Nakayama K, Dustin LB, Loh DY. T-B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl-2-deficient mice. J Exp Med 1995; 182:1101-9.
38. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239:617-22.
39. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly R-P, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176:1099-106.
40. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-6.
41. Lane HC. Interferons in HIV and related diseases. AIDS 1994; 8(Suppl. 3):S19-23.
42. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br J Haematol 1994; 88:268-74.
43. Akbar AN, Borthwick NJ, Wickremasinghe RG et al. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax bcl-xS) gene expression. Eur J Immunol 1996; 26:294-9.
44. Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon-α, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 1994; 13:5605-15.
45. Yang Y, Minucci S, Ozato K, Heyman RA, Ashwell JD. Efficient inhibition of activation-induced Fas ligand upregulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem 1995; 270:18672-7.
46. Zhang X, Giangreco L, Broome HE, Dargan CM, Swain SL. Control of CD4 effector fate: transforming growth factor β1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J Exp Med 1995; 182:699-709.